131-I-MIBG Therapy for Refractory Neuroblastoma and Metastatic Paraganglioma/Pheochromocytoma

Expanded access is currently available for this treatment.
Verified May 2015 by Children's Hospital of Philadelphia
Sponsor:
Information provided by (Responsible Party):
John Maris, Children's Hospital of Philadelphia
ClinicalTrials.gov Identifier:
NCT01163383
First received: July 13, 2010
Last updated: May 24, 2015
Last verified: May 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: Expanded access is currently available for this treatment.
  Estimated Study Completion Date: July 2015
  Estimated Primary Completion Date: July 2015 (Final data collection date for primary outcome measure)